Evidence for MSK-HQ: Validity, Reliability & Clinical Utility

Evidence for the MSK-HQ

Psychometric Properties, Clinical Utility, and Implementation Feasibility

What is the MSK-HQ?

A patient-reported outcome measure (PROM) designed for broad application across diverse musculoskeletal conditions. It consists of 14 items scored 0-56.

Pain Severity

Physical Function

Sleep Quality

Psychological Well-being

What the Evidence Says

Comprehensive validation studies confirm the MSK-HQ as a robust tool for routine clinical practice across diverse populations.

Strong Validity

Correlates well with EQ-5D and condition-specific measures, capturing what matters to patients.

Excellent Reliability

High test-retest stability (ICC > 0.84) ensures consistent scoring in stable patients.

Responsive to Change

Sensitive enough to detect meaningful clinical improvements after treatment interventions.

Reliability & Reproducibility

The MSK-HQ demonstrates excellent test-retest reliability in stable patients.

[2][3] Hill et al. (2016); Norton et al. (2019)

Responsiveness to Change

Discriminating Global Improvement

Detects greater change than EQ-5D

MCID: 5.5

Minimal Clinically Important Difference at 6 months

Construct Validity

Strong Correlation (>0.8)

HAQ, EQ-5D Index, PS-AID, ASQoL, Oxford Hip/Knee Scores

Moderate Correlation

Oxford Shoulder Score

MSK-HQ vs. EQ-5D-5L

MSK-HQ

EQ-5D-5L

No floor/ceiling effects observed

Higher sensitivity to mild MSK issues

Captures broader holistic MSK health

Significant ceiling effects

Less responsive in mild MSK cohorts

Generic health measure

Feasibility & Implementation

Time Efficient

Brief administration time (14 items); suitable for busy clinics.

Acceptability

High completion rates (>90%) across commissioning pilots.

Validation in Diverse Cohorts

Primary Care MSK

Broad pain groups: Back, Neck, Shoulder, Knee (n=524)

Inflammatory Arthritis

High completion and valid scaling (n=287)

International adaptations available (e.g., Hungarian 2022).

Clinical Summary: Positives vs. Negatives

Strengths (+)

Limitations (-)

• Evidence shows positives significantly outweigh negatives • Strong responsiveness (AUC 0.81) • Holistic tracking (Pain, Function, Mood) • No floor/ceiling effects • Single tool for mixed caseloads

• Moderate correlation with some specific joins (e.g. Shoulder) • Less granular for single-joint mechanics than site-specific tools

Key Takeaway

The MSK-HQ is a robust, responsive, and valid instrument that supports clinical decision-making across the MSK spectrum.

Its psychometric strength lies in its ability to detect change where generic tools fail, making it highly effective for monitoring treatment impact.